Intravenous Micronutrients
High-dose vitamin C and nutrient infusions
High-dose intravenous vitamin C and individually selected nutrient infusions are available at St. George Hospital. Your physician reviews the treatment goal, relevant blood tests and current medicines before deciding which preparation belongs in your plan.

High-dose intravenous vitamin C
Intravenous vitamin C is administered directly into the circulation and produces a different exposure from oral supplementation. At St. George Hospital it is considered within an individual plan, including integrative oncology. The treatment goal and its relationship to your other care are discussed before an infusion is prescribed.
A small randomized study in metastatic pancreatic cancer reported improved survival when intravenous vitamin C was added to a particular chemotherapy combination. This does not establish the same effect in other cancers or when vitamin C is used alone. Our guide to vitamin C in cancer care provides further context.
Vitamin and nutrient formulations
Nutrient infusions are selected according to the clinical question and relevant findings. A formulation intended to address a nutritional need is different from high-dose vitamin C used alongside cancer care. Your physician explains which substances are proposed and why the intravenous route is appropriate.
For protein building blocks, see amino acid infusions. The wider infusion service also includes other medicines and preparations, each requiring its own assessment.
An individually planned infusion
Review
Your physician considers the diagnosis, nutritional needs, medicines and blood results.
Prepare
The team explains the selected formulation and checks that it is appropriate for the planned treatment.
Monitor
The infusion is monitored and any symptoms are recorded. Further treatment depends on response and tolerability.
Safety and coordination
Before high-dose vitamin C, the assessment considers G6PD status, kidney function and stone history, fluid balance, iron-overload conditions and current medicines. The US National Cancer Institute's patient information describes these concerns and notes that IV vitamin C is not FDA-approved as a cancer treatment.
Infusions also carry risks such as irritation at the cannula site or reactions to the preparation. Tell the team about unexpected symptoms during treatment. The schedule is coordinated with your other care rather than copied from a general infusion menu.
Your plan and costs
Start with a free inquiry to the International Office. After medical review, the proposed plan and written cost overview explain which infusions are included. The number and duration of sessions depend on your individual treatment.
Frequently asked questions
Is high-dose vitamin C the same as a general vitamin drip?
No. High-dose intravenous vitamin C has its own rationale and safety assessment. A nutrient formulation selected for a deficiency is a different treatment decision.
Why are G6PD and kidney function relevant?
High-dose vitamin C can cause red-cell breakdown in people with G6PD deficiency, and kidney disease or a tendency to stones can affect suitability. These concerns are reviewed before treatment.
Can a vitamin C study predict my cancer outcome?
No. Results depend on the cancer, stage and accompanying treatment studied. Your oncologist should explain whether a study is relevant to the proposed plan.
References
- A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer. Redox Biology 2024. PMID 39369582
- Intravenous Vitamin C (PDQ): Patient Version. Source
Send a free inquiry
The initial inquiry is free of charge. The International Office reviews your message and your case directly and gets back to you.
- Phone
- +49 8061 398-0
- Hours
- Mon–Thu 08:00–17:00, Fri 08:00–14:00 German time (CET/CEST); in the US Mon–Thu 2–11 a.m. ET, Fri 2–8 a.m. ET.
Munich Airport (MUC), about 60 minutes by car.